Kayihura Manigaba

Kayihura Manigaba, Pharm.D., BCIDP

Clinical Assistant Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-8474
Business Email: manigk@ufl.edu

About Kayihura Manigaba

Dr. Kayihura Manigaba received his doctor of pharmacy degree from the University of Tennessee College of Pharmacy in Memphis, TN. He then completed an ASHP-accredited PGY-1 Pharmacy Residency, followed by an ASHP-accredited PGY2 Residency in Infectious Diseases at UF Health Shands Hospital in Gainesville, Florida. In December 2021, Dr. Manigaba joined the University of Florida College of Pharmacy from North Florida Regional Medical Center (NFRMC), where he was an Advanced Clinical Pharmacist in Infectious Diseases and, most recently, a Clinical Pharmacy Manager. While at NFRMC, Dr. Manigaba contributed to the UF College of Pharmacy program by teaching in the Patient Care 2 course and precepting APPE students. Dr. Manigaba is board certified in infectious diseases pharmacy, and his professional and research areas of interest include infectious diseases, therapeutic drug monitoring, treatment of multidrug-resistant pathogens, and antimicrobial stewardship. He is a member of the American Society of Health-System Pharmacists and the American College of Clinical Pharmacy.

Teaching Profile

Courses Taught
2021-2023
PHA5782C Patient Care 2: Introduction to Infectious Disease and Oncology
2022
PHA5784C Pt Care 4: GI and Renal
2022
PHA5166L Prof Skills Lab Vi
2022
PHA5787C Pt Care 5: Endo

Publications

2022
A waterfall of susceptibility results: impact of microbiology testing cascade for MDROs.
Diagnostic microbiology and infectious disease. 104(1) [DOI] 10.1016/j.diagmicrobio.2022.115731. [PMID] 35841735.
2021
A new frontier: navigating hospital pharmacy practice during the COVID-19 pandemic.
Journal of Research in Pharmacy. 25(6)
2020
COVID-19: The Culprit, the People and Lessons Learned
HCA Healthcare Journal of Medicine . 1(4)
2020
Remdesvir-warfarin interaction: A case report
HCA Healthcare Journal of Medicine. 1(COVID-19)
2018
SCAN: A novel approach for vancomycin time-out.
Infection control and hospital epidemiology. 39(12):1501-1503 [DOI] 10.1017/ice.2018.249. [PMID] 30303049.
2018
Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.
Microbiology insights. 11 [DOI] 10.1177/1178636118804549. [PMID] 30349291.
2017
Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
Antimicrobial agents and chemotherapy. 61(9) [DOI] 10.1128/AAC.00651-17. [PMID] 28630186.
2015
Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
Antimicrobial agents and chemotherapy. 59(10):5942-50 [DOI] 10.1128/AAC.01358-15. [PMID] 26169412.
2013
Ethnic differences in DNA methyltransferases expression in patients with systemic lupus erythematosus.
Journal of clinical immunology. 33(2):342-8 [DOI] 10.1007/s10875-012-9803-z. [PMID] 23054340.

Contact Details

Phones:
Business:
(352) 273-8474
Emails:
Business:
manigk@ufl.edu
Addresses:
Business Mailing:
PO Box 100486
GAINESVILLE FL 32610